CORT Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Corcept Therapeutics Inc. Class Action Lawsuit

SAN DIEGO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Corcept Therapeutics Incorporation (NASDAQ: CORT) common stock between October 31, 2024 and December 30, 2025. Corcept is a pharmaceutical company focused on the development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol. For more information, s ...